Stock 000590 TUS-PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tus-Pharmaceutical Group Co., Ltd.

Equities

000590

CNE000000701

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
6.64 CNY -0.90% Intraday chart for Tus-Pharmaceutical Group Co., Ltd. -3.91% -25.89%
04-25 Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-27 Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Tus Pharmaceutical Group Co Ltd, formerly Tus-Guhan Group Corp Ltd, is principally engaged in the manufacture and sale of pharmaceuticals. The Company provides Chinese medicines, including Chinese healthcare products, medicines for cold treatment and anti hyperlipemia medicines, among others. It also provides western medicine preparations, including clindamycin phosphate for injection, lomefloxacin hydrochloride for injection and levofloxacin lactate for injection, among others. The Company distributes its products in domestic markets.

Number of employees: 1,237

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Medicine Health Care Production
96.7 %
332 94.8 % 391 96.7 % +17.76%
Western Medicine Production
2.6 %
17 4.8 % 10 2.6 % -38.42%
Other
0.7 %
1 0.4 % 3 0.7 % +120.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
68.4 %
272 77.6 % 277 68.4 % +1.78%
International
31.6 %
79 22.4 % 128 31.6 % +62.63%

Managers

Managers TitleAgeSince
Ting Tang DFI
 Director of Finance/CFO 46 11/12/16
Xue Feng PSD
 President 34 20/05/20
Li Jun Yan IRC
 Investor Relations Contact - -
Ding Xing Cao SEC
 Corporate Secretary 56 09/06/05

Members of the board

Members of the board TitleAgeSince
Wei Hua Xie BRD
 Director/Board Member 53 10/06/08
Qi Sen Jiao CHM
 Chairman 43 25/10/20
Ke Biao Yan CHM
 Chairman 58 07/06/17
Xue Feng PSD
 President 34 20/05/20
Ting Tang DFI
 Director of Finance/CFO 46 11/12/16
Zheng Ming Huang BRD
 Director/Board Member 77 09/12/20
Jing Wei Sun BRD
 Director/Board Member 39 09/12/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 239,471,267 127,883,332 ( 53.40 %) 0 53.40 %

Shareholders

NameEquities%Valuation
Goldstate Capital Fund Management Co., Ltd.
0.5481 %
1,223,600 0.5481 % 1 M ¥
Wanjia Asset Management Co., Ltd.
0.4953 %
1,105,600 0.4953 % 983 232 ¥
Gfund Management Co., Ltd.
0.2081 %
464,600 0.2081 % 413 178 ¥
Western Leadbank Fund Management Co., Ltd
0.1584 %
353,700 0.1584 % 314 552 ¥
SWS MU Fund Management Co., Ltd.
0.1462 %
326,300 0.1462 % 290 185 ¥
CITIC-Prudential Fund Management Co., Ltd.
0.0986 %
220,000 0.0986 % 195 650 ¥
Truvalue Asset Management Co. Ltd.
0.0320 %
71,500 0.0320 % 63 586 ¥
Hongde Fund Management Co., Ltd.
0.006988 %
15,600 0.006988 % 13 873 ¥
CICC Fund Management Ltd.
0.000090 %
200 0.000090 % 178 ¥

Company contact information

Tus-Pharmaceutical Group Co., Ltd.

1 Luojinqiao Yanfeng District

421001, Hengyang

+

http://www.tuspharma.cn
address Tus-Pharmaceutical Group Co., Ltd.(000590)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TUS-PHARMACEUTICAL GROUP CO., LTD. Stock Tus-Pharmaceutical Group Co., Ltd.
-25.89% 220M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 334B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 203B
AMGEN INC. Stock Amgen Inc.
+10.77% 171B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 163B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000590 Stock
  4. Company Tus-Pharmaceutical Group Co., Ltd.